Search

everythinglearnresearchcommunity

for

Search:↓

Avacopan may cause unexpected side effects, so early monitoring is important.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

ATX-101 injections can cause hair loss.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

NXC736 significantly reduced hair loss in mice with alopecia areata.

JAK inhibitors may help improve symptoms in adults with APECED.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Asynchronous telemedicine for acne treatment is effective and improves access and productivity.

Acitretin effectively improved the woman's skin condition.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Oral Acitretin effectively resolved symptoms in a child with Netherton syndrome.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.